Clinical Trials Logo

Bradycardia clinical trials

View clinical trials related to Bradycardia.

Filter by:

NCT ID: NCT06324682 Recruiting - Atrial Fibrillation Clinical Trials

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

TREEBEARD
Start date: January 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to evaluate the clinical characteristics of patients undergoing permanent cardiac pacing and to compare procedural efficacy and safety of different implantation approaches in the clinical practice of the participating centres. The contribution of non-fluoroscopic anatomical and electrophysiological reconstruction systems to device implantation procedures will also be evaluated. Participants [patients over 18 years old with an indication to receive a definitive pacemaker/intracardiac defibrillator implant] will receive a permanent cardiac pacing implant as requested according to European Society of Cardiology (ESC) guidelines; the investigators will evaluate procedural efficacy and safety of different implantation approaches.

NCT ID: NCT06288633 Recruiting - Bradycardia Clinical Trials

Cardioneuroablation for Bradyarrhythmia

CARDIOBOOST
Start date: March 4, 2024
Phase: N/A
Study type: Interventional

This is a multicenter prospective randomized blind controlled trial with a sham procedure group of the efficacy and safety of cardioneuroablation as a method of treating symptomatic bradycardia without a permanent pacemaker implantation

NCT ID: NCT06276816 Recruiting - Sinus Bradycardia Clinical Trials

Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia

Start date: September 13, 2023
Phase:
Study type: Observational

This is a prospective clinical observation and registration study. The investigator aimed to evaluate the efficacy and safety of cardiac denervation ablation as a treatment strategy for severe sinus bradycardia.

NCT ID: NCT06167434 Recruiting - Atrial Fibrillation Clinical Trials

Future Cardia™ Insertable Cardiac Monitor in Subjects With Paroxysmal Atrial Fibrillation (First-in-Human Study)

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This study is a first-in-human, prospective, multi-center, pre-market single-arm clinical trial to evaluate the Future Cardia™ ICM.

NCT ID: NCT06166277 Not yet recruiting - Vasovagal Syncope Clinical Trials

Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry

CNA-FWRD
Start date: April 1, 2024
Phase:
Study type: Observational [Patient Registry]

The CNA-FWRD Registry is an international prospective observational multicenter registry of patients with symptomatic vasovagal syncope and bradyarrhythmias managed under routine care by medical therapy and radiofrequency catheter ablation of ganglionated plexi or permanent pacemaker implantation.

NCT ID: NCT06159764 Not yet recruiting - Bradycardia Clinical Trials

National Registry of Cardioneuroablation in Recurrent Reflex Syncope

CANVAS-R
Start date: December 15, 2023
Phase:
Study type: Observational [Patient Registry]

This registry aims to collect patient data on cardioneuroablation for vasovagal syncope from multiple centers in France. The aim is to evaluate success rates, compare techniques and help institutions set up their own cardioneuroablation program

NCT ID: NCT06123130 Not yet recruiting - Atrial Fibrillation Clinical Trials

AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection

VALID-ECG
Start date: March 2024
Phase: N/A
Study type: Interventional

The study is a prospective single-arm multicenter clinical trial. Adult patients will be consented and enrolled in an outpatient cardiology office or Arrhythmia Clinics.

NCT ID: NCT06115980 Active, not recruiting - Bradycardia Clinical Trials

Safety and Preliminary Performance of Xtrac O.S. System for Lead Extraction.

XTR
Start date: August 27, 2023
Phase: N/A
Study type: Interventional

This is an open label, interventional, feasibility, prospective, multicenter, clinical trial of lead extraction. The Xtrac O.S. system is intended for transvenous removal of pacing or defibrillator leads, having an inner lumen, through a superior approach. A total of 15 patients, who are scheduled for CIED lead extraction, will be recruited in order to ensure a total of at least 10 patients finishing the study procedures and follow up.

NCT ID: NCT06100770 Recruiting - Arrhythmia Clinical Trials

Aveir AR Coverage With Evidence Development (CED) Study

ARRIVE
Start date: January 18, 2024
Phase:
Study type: Observational

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Atrial Leadless Pacemaker device (aka Aveir™ AR LP system).

NCT ID: NCT06094114 Completed - Bradycardia Clinical Trials

Evaluation of VDD Leadless Pacing System During Exercise

Start date: April 1, 2022
Phase:
Study type: Observational

The study is a non-randomized, active prospective observational study permitting to report the behavior of Micra AV pacemaker during an exercise. Only patients who were previously implanted with a Micra MC1AVR01 can be enrolled in the study. Exercise test is part of the standard clinical care practice for this patients population during the first year follow-up.